Patent · US Expired

Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, and its pharmaceutical use

US5559139A · kind A · utility

0Cited by

8References

3Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Otto Behner · Wuppertal, DE
Hartmund Wollweber · Wuppertal, DE
Bruno Rosen · Wülfrath, DE
Siegfried Zaiss · Wuppertal, DE
Siegfried Goldmann · Wuppertal, DE

Key dates

Filing date	Jul 13, 1993
Grant date	Sep 24, 1996
Priority date	—
Expiry date	Jul 13, 2013

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the new dimethyl 4-(4-chloro-3-trifluoromethylphenyl) -1-cyclopropyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, a process for its preparation and its use as a medicament in ischaemic diseases which are associated with disorders of the microcirculation. This action can occur both in the peripheral and in the cerebral vascular system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.